[Protracted manganese-induced encephalopathy. Preliminary results of treatment with Sinemet preparation].
D000328:Adult; D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001927:Brain Diseases / Q000139:chemically induced / Q000188:drug therapy*; D002230:Carbidopa / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D004338:Drug Combinations / Q000009:adverse effects / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008345:Manganese / Q000009:adverse effects*; D008875:Middle Aged; D009784:Occupational Diseases / Q000188:drug therapy*
D000978:Antiparkinson Agents; D004338:Drug Combinations; C009265:carbidopa, levodopa drug combination; D008345:Manganese; D007980:Levodopa; D002230:Carbidopa
Przewlekła encefalopatia manganowa. Wstepne wyniki leczenia preparatem sinemet.